Testimonials

GCS works with you to develop commercialization and growth strategies tailored to your unique requirements. Read what some of our satisfied clients have to say about our work.

Catholic Health Initiatives

Catholic Health Initiatives, a national healthcare organization, established the Center for Translational Research to develop cutting-edge diagnostic and laboratory services for patients and clinicians within the 78-hospital system. GCS worked with CTR to refine the portfolio of proposed services and develop a commercialization roadmap.

I hired Brian Taylor and Growing Company Solutions to develop a commercialization strategy for our newly-established Center for Translational Research. Brian met with stakeholders throughout the organization and surveyed CHI physicians to understand our internal market. He then molded competitor, supplier, and customer data into a comprehensive review of the external market. Brian has a deep understanding of science and business, and provided us with a roadmap for the future and practical recommendations that helped us respond quickly to new opportunities. Beyond these things, I was personally very pleased by the value-add that he provided through making meaningful and important introductions through his extensive network.

Jeffrey Otto, National Director, Center for Translational Research, Catholic Health Initiatives

Solutions: Comprehensive Analysis

QBM Cell Science

QBM Cell Science, an Ottawa neuroscience company, needed a global distributor for cryopreserved neuronal cells from mice and rats. GCS identified Cambrex Biosciences (now Lonza) as an excellent prospect with complementary products. We worked with QBM and Cambrex to negotiate a deal that laid the foundation for a successful long-term partnership.

I was impressed by Brian’s ability to quickly get a handle on the science of cryopreserved neurons and see the market for our products. He used his broad market knowledge and industry contacts to identify several strong potential distribution partners and represented QBM in subsequent contract negotiations. QBM Cell Science benefited significantly from his strategic insight, thorough preparation, and strong negotiating skills.

Dr. Anthony Krantis, President, QBM Cell Science

Solutions: Comprehensive Analysis, Business Development

Expression Pathology, Inc.

Expression Pathology, a proteomics and biomarker discovery company, retained Dr. Taylor as an interim VP of Business Development. Dr. Taylor worked with the EPI management team to obtain several essential intellectual property licenses and negotiate agreements with research collaboration partners.

Brian quickly came up to speed on the technology relating to protein extraction from FFPE tissue and analysis of complex peptide mixtures by mass spectrometry, and represented the company well in discussions with customers, scientific collaborators, and potential partners. He had an excellent grasp of trends in biomarker discovery and personalized medicine, and worked with EPI’s management team to refine our corporate strategy. As VP of Business Development, Brian negotiated several important licensing, partnering, and biomarker discovery deals for EPI. He did an excellent job of resolving issues and taking the deals to completion.

Casey Eitner, President and CEO, Expression Pathology Inc.

Solutions: Business Development, Retainer Services

Larta Institute

Larta Institute is a Los Angeles non-profit that fosters innovation and entrepreneurship by working with government agencies to support growing businesses, driving the commercialization of products from sponsored research. Dr. Taylor serves as a Principal Advisor to companies receiving SBIR Phase II funding from the National Institutes of Health and U.S. Department of Agriculture. In this role, he works with company CEOs and other senior managers to enhance their product commercialization strategies and interact effectively with early-stage investors, partners, and customers.

As a Larta Principal Advisor, Brian helps companies with products ranging from vaccines to medical devices sharpen their business models, target customers, and engage with investors and distribution partners. The response to his work from our clients and Larta staff has been very positive, and we use examples of his work in our consultant orientation sessions.

Rohit Shukla, CEO, Larta Institute

Solutions: Retainer Services

Center for Molecular Medicine

The Board of Directors of the Center for Molecular Medicine in Grand Rapids, MI, asked GCS to review their business model and recommend strategies for increasing profitability and driving adoption of cutting-edge molecular diagnostics assays. Dr. Taylor interviewed board members, customers, employees, and collaborators, and researched the applications and markets targeted by CMM. GCS provided the Board with a comprehensive summary of this work and a set of actionable recommendations.

With his in-depth technical knowledge and clear understanding of the issues involved in advancing personalized medicine, Brian quickly assessed our challenges and opportunities. He offered recommendations that were practical and would have significantly enhanced our business model, were we not profitably acquired before they could be implemented.

Daniel H. Farkas, Ph.D., HCLD, former Executive Director, Center for Molecular Medicine

Solutions: Comprehensive Analysis

Biotech Venture Management

Dr. Taylor collaborated with Casimir (Casey) Eitner, BVM‘s Managing Partner, to offer joint management expertise on a retainer basis for clients in the research products market. Casey is a former Life Technologies Vice-President with extensive experience in laboratory products management.

As a Senior Partner at Biotech Venture Management, Brian provided part-time Director of Business Development services to KPL over a 15-month period. Brian was an integral part of KPL’s management team, working with Marketing to negotiate licensing deals for products and technology and interfacing effectively with Sales and Finance. He helped us clarify our product and company strategies and work through a number of long-standing issues. I heartily recommend his services.

Albert Perry, President and CEO, KPL Inc.